Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
公司代碼XTNT
公司名稱Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
員工數量217
證券類型Ordinary Share
年結日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編59714
電話14063880480
網址https://xtantmedical.com/
公司代碼XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)